RecruitingNCT03588975
A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Interventional studyAges 10–17United StatesOCD
Understand this study
Who could participate?
Listed age limits: 10 years to 17 years.
- Listed locations
- Palo Alto and 13 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: October 24, 2018
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 45
- Sponsor
- Vericel Corporation
- Sponsor type
- Other organization
- Study type
- Biological
- Intervention type
- BIOLOGICAL, PROCEDURE
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 10 Years to 17 Years
- Official registry ID
- NCT03588975
- Official title
Show the full official title
A Prospective, Open-label, Randomized, Concurrent Active-controlled, Longitudinal, Multicenter, Phase 3 Clinical Study of the Safety and Efficacy of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Palo Alto · Sacramento · New Orleans
10 more locations
- Baltimore
- Ann Arbor
- The Bronx
- Akron
- Columbus
- Philadelphia
- East Providence
- Houston
- Plano
- Milwaukee
Questions about this study
Who is behind this study?
The study sponsor is Vericel Corporation.
Who can participate?
Listed age limits: 10 years to 17 years.
Is this study still recruiting?
The registry lists this study as recruiting.
